2022 NHMRC Synergy Grant
"Mining the host-pathogen interface to deliver a drug pipeline for treating intractable and emerging infections"
Emerging viruses and antibiotic-resistant superbugs are the most important challenge to human health in the 21st century. New viruses such as SARS-CoV2 and Zika, as well as antibiotic resistant superbugs, emerge regularly and rapidly, urgently requiring new therapies.
Kate is leading the multidisciplinary Synergy team, including Prof Mark von Itzstein (Griffith Uni), Dr Lara Herrero (Griffith Uni), Prof Mark Walker (UQ) and Emer Prof Maree Smith (UQ). This team has demonstrated success in drug development and will work together to create new drugs to avert the imminent global health disaster posed by emerging viruses and superbugs.
Brava to all!
Copyright © 2017 - The University of Queensland